Tongji Hospital clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 3 with minor changes only.

1. Notable

   NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

   Primary completion pushed from Nov 30, 2026 to Nov 30, 2027

   Tongji Hospital·Phase 1· NCT06620809· Registry history of NCT06620809 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

2. Notable

   Mindfulness Intervention on Minimally Invasive Vascular Surgery

   Primary endpoint(s) modified

   Also in this update: Primary completion pushed from Jan 2027 to Jun 2027; Study completion pushed from Jan 2027 to Jul 2027

   Tongji Hospital·Not applicable· NCT07463638· Registry history of NCT07463638 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

3. Notable

   Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With…Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

   Recruitment opened

   Tongji Hospital·Phase 2· NCT07417501· Registry history of NCT07417501 on ClinicalTrials.gov (opens the registry)

   Oct 14, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.